Feed

30/11/2022
CMS ad­vises Syn­er­gie on the ac­quis­i­tion of In­ter­Kadra
Ber­lin – In­ter­na­tion­al law firm CMS has ad­vised French Group Syn­er­gie on its ac­quis­i­tion of Pol­ish tem­por­ary em­ploy­ment agency In­ter­Kadra. Syn­er­gie Group is one of the top five glob­al groups op­er­at­ing...
28/11/2022
CMS ad­vises IT ser­vice pro­vider Bechtle on ac­quis­i­tion of Brit­ish IT sys­tem...
Stut­tgart – Neck­ar­sulm-based Bechtle AG has ac­quired Brit­ish firm ACS Sys­tems UK Ltd., which is headquartered in Northamp­ton. This latest step in Bechtle AG’s ac­quis­i­tion strategy marks a fur­ther...
24/11/2022
The Cor­por­ate Sus­tain­ab­il­ity Re­port­ing Dir­ect­ive (CSRD) has been ad­op­ted
After lengthy ne­go­ti­ations between the European in­sti­tu­tions, which in­cluded amongst oth­er things the timetable and the wide scope of the dir­ect­ive and a pre­lim­in­ary polit­ic­al agree­ment in June 2022...
23/11/2022
Ex­pan­sion strategy: CMS ad­vises NORD Hold­ing on ex­pand­ing Pub­lic Cloud...
Co­logne – The Pub­lic Cloud Group has ex­pan­ded its port­fo­lio of ser­vices by ac­quir­ing Erd­ing-based SAP spe­cial­ist LNW-Soft. The ac­quis­i­tion will en­able the multi-cloud ser­vice pro­vider to mi­grate its...
23/11/2022
State aid: ex­ten­sion of the Tem­por­ary Crisis Frame­work to sup­port the eco­nomy...
Many busi­nesses and in­di­vidu­als have been im­pacted dir­ectly or in­dir­ectly by the crisis res­ult­ing from Rus­si­a's in­va­sion of Ukraine, as well as the re­per­cus­sions of all the eco­nom­ic sanc­tions ad­op­ted...
22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022 – re­cord­ings & present­a­tions
Un­cer­tain times, an evolving leg­al frame­work: man­aging risks and en­sur­ing so­cial re­spons­ib­il­ity in the life sci­ences & health­care sec­tor The risks of AI in the fu­ture of life sci­ences came un­der the mi­cro­scope at a land­mark leg­al For­um in Septem­ber.Health­care is ra­cing ahead in ad­opt­ing new tech­no­lo­gies across drug dis­cov­ery, de­vel­op­ment, man­u­fac­tur­ing and sup­ply chain but ex­perts pre­dict a tail-whip of dis­putes and con­tract fric­tion.Di­git­al trans­form­a­tion has the po­ten­tial to im­prove every as­pect of health­care and the pharma in­dustry but it also im­pacts data pro­tec­tion, IT se­cur­ity, con­tract design, li­ab­il­ity and reg­u­la­tion.The an­nu­al CMS Glob­al Life Sci­ences and Health­care For­um brought to­geth­er high-level in­dustry and leg­al ex­perts to dis­cuss sec­tor in­tel­li­gence and best prac­tice as well as is­sues ran­ging from cy­ber breaches and crypto­cur­rency wrangles to fall-outs over trade secrets and in­tel­lec­tu­al prop­erty (IP).“AI of­fers amaz­ing op­por­tun­it­ies to ad­vance life sci­ences and ush­er in trans­form­at­ive medi­cine such as cell and gene ther­apy, im­proved dia­gnostics and ana­lyt­ics but it also comes with con­cerns as leg­al and con­trac­tu­al risks are still be­ing un­der­stood and eval­u­ated,” says Nick Beck­ett, Glob­al Co-Head of CMS Life Sci­ences & Health­care Sec­tor Group“Sci­ence and tech­no­logy are mov­ing for­ward very quickly but we are find­ing that the de­tail and strategy of what to do to mit­ig­ate risks or re­solve them is lag­ging be­hind. These are crit­ic­ally im­port­ant is­sues that com­pan­ies need to ad­dress and the For­um ex­amined the im­plic­a­tions and solu­tions.”AI is boom­ing and a re­cent re­port by ana­lysts Grand View Re­search fore­cast that the glob­al AI in health­care mar­ket will grow from its cur­rent value of $10.4 bil­lion at a com­pound an­nu­al growth rate (CAGR) of 38.4% from 2022 to 2030. AI is fast be­com­ing a sig­ni­fic­ant ele­ment of every as­pect of health­care and leg­al de­part­ments and busi­ness units are be­ing chal­lenged to re­spond.The For­um, which was held in Brus­sels and on­line on Thursday, Septem­ber 29, had a packed agenda cov­er­ing tech­no­logy trans­form­a­tion, En­vir­on­ment­al, Sus­tain­ab­il­ity and Gov­ernance, sup­ply chain dis­rup­tion, reg­u­lat­ory frame­works and the chan­ging com­mer­cial land­scape.The scale of chal­lenge was evid­enced in the re­cent CMS Tech­no­logy Trans­form­a­tion: Man­aging Risks in a Chan­ging Land­scape re­port which re­vealed that 56% of cor­por­ate coun­sel and risk man­agers ex­pect an in­crease in AI-re­lated dis­putes, while 50% be­lieve that the use of AI tech­no­lo­gies will lead to risks and dis­putes that can­not cur­rently be fore­seen.Dis­putes will be driv­en by is­sues arising from IP and trade secrets, the use of AI, smart con­tracts, crypto­cur­ren­cies and cloud ser­vices, they be­lieve.“Or­gan­isa­tions are likely to see new types of risks and dis­putes emerge from the use of new tech­no­lo­gies such as AI and crypto­cur­ren­cies. Many busi­nesses are play­ing catch-up in un­der­stand­ing the risks as­so­ci­ated with these new tech­no­lo­gies,” says Lee Gluyas, Part­ner, CMS. “Whilst no busi­ness can elim­in­ate risks com­pletely, those that think ahead, plan early and act­ively man­age risk will give them­selves a sub­stan­tial ad­vant­age.”Fea­tured key­note speak­ers from the United Na­tions Health and De­vel­op­ment Team, gen­er­al coun­sel from lead­ing pharma com­pan­ies, Bo­ston Con­sult­ing Group, fin­an­cial ser­vices mul­tina­tion­al Aon and CMS sec­tor spe­cial­ists.
22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: Life Sci­ences are reap­ing...
Di­git­al trans­form­a­tion in life sci­ences is cre­at­ing op­por­tun­it­ies to counter health­care’s most in­tract­able prob­lems from treat­ing rare dis­eases to ac­cel­er­at­ing dia­gnostics and re­du­cing treat­ment back­logs...
21/11/2022
State aid: The Court of Justice of the EU an­nuls the Com­mis­sion’s de­cision...
On 8 Novem­ber 2022, the Court of Justice of the EU (CJEU) an­nulled the judg­ment of the Gen­er­al Court held on 24 Septem­ber 2019, which re­jec­ted the ac­tion brought by the Grand Duchy of Lux­em­bourg and Fi­at...
16/11/2022
Com­pre­hens­ive ad­vice on se­cur­ing en­ergy sup­ply in Ger­many
Ham­burg/Stut­tgart – Strug­gling gas com­pany Se­cur­ing En­ergy for Europe (SEFE) has been trans­ferred to the own­er­ship of the Fed­er­al Re­pub­lic of Ger­many in or­der to se­cure Ger­man gas sup­plies. SEFE is...
16/11/2022
Ar­ti­fi­cial in­tel­li­gence in HR man­age­ment
I. In­tro­duc­tion Of­ten de­scribed as the key tech­no­logy of the fu­ture, ar­ti­fi­cial in­tel­li­gence (AI) holds many prom­ises. Ar­ti­fi­cial in­tel­li­gence is a term used in a wide vari­ety of con­texts today, but it...
15/11/2022
Déjà vu for Louis Vuit­ton’s Dam­i­er Azur pat­tern?
In­tro­duc­tion It could be ar­gued that the ma­jor­ity of con­sumers would re­cog­nise the in­fam­ous Dam­i­er Azur pat­tern be­long­ing to French lux­ury fash­ion house, Louis Vuit­ton Mal­leti­er (Louis Vuit­ton). Pre­vi­ous...
15/11/2022
Five myths about anti-dis­crim­in­a­tion law in Ger­many
The end of dis­crim­in­a­tion in every­day life seems a long way off. Dis­crim­in­a­tion is of­ten the res­ult of ig­nor­ance. A good reas­on to learn more about anti-dis­crim­in­a­tion law. Not only in the United States...